Expansion of circulating CD56brightnatural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α

Interferon-Alpha in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Status and Perspectives

(2012) Hans Carl Hasselbalch et al.   CURRENT DRUG TARGETS

The renaissance of interferon therapy for the treatment of myeloid malignancies

(2011) J.-J. Kiladjian et al.   BLOOD

Increase in circulating CD4+CD25+Foxp3+ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN- 

(2011) C. H. Riley et al.   BLOOD

Direct Effects of Type I Interferons on Cells of the Immune System

(2011) S. Hervas-Stubbs et al.   CLINICAL CANCER RESEARCH

IFN-α primes T- and NK-cells for IL-15-mediated signaling and cytotoxicity

(2011) Mikkel L. Hansen et al.   MOLECULAR IMMUNOLOGY

Complete molecular remission in a polycythaemia vera patient 12 years after discontinuation of interferon-alpha

(2010) Philip T. Murphy et al.   ANNALS OF HEMATOLOGY

Revisiting human natural killer cell subset function revealed cytolytic CD56dimCD16+ NK cells as rapid producers of abundant IFN-  on activation

(2010) A. De Maria et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Regulation of human NK-cell cytokine and chemokine production by target cell recognition

(2009) C. Fauriat et al.   BLOOD

Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remission

(2009) Thomas Stauffer Larsen et al.   Hematology

NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs

(2009) B. Morandi et al.   INTERNATIONAL IMMUNOLOGY

Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera

(2009) Alfonso Quintás-Cardama et al.   JOURNAL OF CLINICAL ONCOLOGY

Sustained major molecular response on interferon alpha-2b in two patients with polycythemia vera

(2008) T. S. Larsen et al.   ANNALS OF HEMATOLOGY

Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera

(2008) J.-J. Kiladjian et al.   BLOOD

Human natural killer cells

(2008) M. A. Caligiuri   BLOOD

CD56brightnatural killer (NK) cells: an important NK cell subset

(2008) Aurélie Poli et al.   IMMUNOLOGY

Natural Killer Cells in Innate Immunity and Cancer

(2008) Brian Becknell et al.   JOURNAL OF IMMUNOTHERAPY